06252017Headline:

Dallas-Fort Worth, Texas

HomeTexasDallas-Fort Worth

Email Shezad Malik MD JD Shezad Malik MD JD on LinkedIn Shezad Malik MD JD on Twitter Shezad Malik MD JD on Facebook Shezad Malik MD JD on Avvo
Shezad Malik MD JD
Shezad Malik MD JD
Attorney • (888) 210-9693

Invokana Ketosis Side Effects leads to lawsuit

1 comment

Invokana Ketosis Side Effects leads to lawsuit, filed in the federal court system claiming that side effects of Invokana caused a patient to develop severe dehydration and profound ketosis.

Invokana Ketosis Side Effect Lawsuits

Invokana diabetic drug is linked to life threatening side effects including kidney damage

Teresa Ross from Indiana, filed her product liability lawsuit in the U.S. District Court for the District of New Jersey blaming Johnson & Johnson, Janssen subsidiaries, and Mitsubishi Tanabe Pharma Corp. for her serious injuries.

According to Ross, she was prescribed Invokana in 2013, for treatment of her type 2 diabetes. In March 2015, Ross developed ketosis and dehydration, from using Invokana.

What is Ketosis?

Ketosis occurs when high levels of ketones are present in the body, and is usually caused by starvation, low levels of carbohydrates, intense and prolonged physical activity or uncontrolled type 1 diabetes. Ketosis can develop into ketoacidosis, where high blood acid levels lead to organ damage and requires hospitalization for treatment.

Ross alleges that inadequate warnings about the potential side effects of Invokana were provided to patients or the doctors.

Ross claims that “Plaintiff’s injuries were preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions, and willful misrepresentations concerning the nature and safety of Invokana.”

What is Invokana?

Invokana (canagliflozin) was released in 2013, and is a new class of diabetes meducations known as sodium glucose cotransporter 2 (SGLT-2) inhibitors. Invokana affects some normal kidney functions, allowing the kidney to increase the amount of sugar excreted in the urine.

FDA Invokana Ketosis Warnings

In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, warning patients to seek immediate medical attention if they experience symptoms like abdominal pain, fatigue, nausea, respiratory problems or vomiting.

In June 2016, the FDA required another warning label update to add information about the link between Invokana and kidney problems, warning that the medication may increase the risk of acute kidney injury and other serious health complications.

Federal Invokana Multidistrict Litigation

Federal Invokana product liability and personal injury cases are consolidated as part of a federal MDL (multidistrict litigation), which is centralized before U.S. District Judge Brian Martinotti in the District of New Jersey to coordinate discovery and pretrial proceedings.

If you or someone you know succumbed to an Invokana Ketoacidosis or kidney failure from taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr Shezad Malik Law Firm is investigating Invokana Ketoacidosis or kidney failure from taking Invokana for the treatment of their type 2 diabetes.

1 Comment

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

  1. nancy says:
    up arrow

    i was hosptial with kidney promble ok thanks nancy all do to metformin k